High Copayments For "Specialty Pharmacy" Medications Has Little Effect On Use, Report Says

Main Category: Health Insurance / Medical Insurance
Also Included In: Cancer / Oncology;  Multiple Sclerosis
Article Date: 14 Sep 2006 - 17:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:3 stars

3 (2 votes)

Healthcare Prof:4 stars

4 (1 votes)


Higher copayments have a small effect on usage of "specialty pharmacy" medications, which can cost as much as $10,000 monthly, according to a study published Tuesday in the journal Health Affairs, the Pittsburgh Post-Gazette reports. Health insurers often place specialty pharmacy medications -- injectable and biological medications that target a gene or protein and often are used to treat complex chronic conditions such as anemia, cancer and multiple sclerosis -- on the "fourth tier" of prescription drug formularies and require members to pay 25% copays for the treatments, with maximum out-of-pocket payments of $1,000 annually. However, the study, led by Dana Goldman, chair and director for health economics at RAND, finds that higher copays for specialty pharmacy medications reduce usage by only 1% to 21%, compared with 30% to 50% for traditional treatments. "Insurance markets work best when there is the chance of substantial loss, when that loss is sufficiently rare and uncertain, and when the presence of coverage will not alter behavior much," according to the study. As a result, specialty pharmacy medications "appear to warrant greater, not less, coverage than traditional pharmaceutical agents," the study finds. Goldman said, "Patients are desperate for these drugs, and they're willing to pay quite a bit to try whatever is out there," adding, "Even though they're expensive, that cost is spread over a very large insurance pool, so, socially, it makes sense that we should cover them" (Snowbeck, Pittsburgh Post-Gazette, 9/12).

The study is available online.

"Reprinted with permission from http://www.kaisernetwork.org. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Daily Health Policy Report is published for kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation . © 2005 Advisory Board Company and Kaiser Family Foundation. All rights reserved.

Article adapted by Medical News Today from original press release.
Visit our health insurance / medical insurance section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
Barbara Martin. "High Copayments For "Specialty Pharmacy" Medications Has Little Effect On Use, Report Says." Medical News Today. MediLexicon, Intl., 14 Sep. 2006. Web.
15 Feb. 2012. <http://www.medicalnewstoday.com/releases/51745.php>

APA
Barbara Martin. (2006, September 14). "High Copayments For "Specialty Pharmacy" Medications Has Little Effect On Use, Report Says." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/51745.php.

Please note: If no author information is provided, the source is cited instead.


Health Insurance / Medical Insurance

Most Popular Articles



Follow Our Health Insurance News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Health Insurance / Medical Insurance Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »